BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:40 PM
 | 
Apr 23, 2009
 |  BC Extra  |  Company News

Acorda gains after resubmitting NDA

Acorda Therapeutics Inc. (NASDAQ:ACOR) rose $3.55 (19%) to $21.89 on Thursday after resubmitting an NDA to FDA for Fampridine-SR...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >